Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter Aortic Valve Implantation System™ ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced authorization from the Competent Authority of Poland to expand the TAVI-1 CE Mark trial of the Optimum Transcatheter ...

Edwards Lifesciences (NYSE: EW) today announced the results from the RHEIA Trial, a first-of-its-kind trial focused exclusively on outcomes for women receiving transcatheter aortic valve implantation ...

Chennai's MGM Healthcare performs innovative valve and leadless pacemaker implantation without open-heart surgery, enhancing ...

Transcatheter aortic valve implantation (TAVI) was superior to surgical aortic valve replacement for reducing death, stroke or rehospitalization in women with severe aortic stenosis, according to late ...

ABBOTT PARK, Ill., March 5, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for the new FlexNav™ delivery system for the company's Portico™ transcatheter aortic valve ...

PARIS, France—For patients undergoing transcatheter valve-in-valve (ViV) procedures to treat a small failed aortic bioprosthesis, self-expanding devices outperform balloon-expandable devices at 30 ...

COLLEGEVILLE, Pa.--(BUSINESS WIRE)--Thubrikar Aortic Valve, Inc. today announced successful results in an additional 5 patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) ...

PHOENIX, AZ—Patients who require cardiac surgery on another valve after initially being treated with TAVI have very high operative morbidity and mortality, with a 30-day death rate exceeding 17%, ...

A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, has identified early hemodynamic valve deterioration (HVD) in more than 6% of patients just ...